DAMORA THERAPEUTICS, INC. (DMRA) Operating income 2019–2025
DAMORA THERAPEUTICS, INC. (DMRA) annual operating income history from SEC filings — each fiscal year as reported.
-$210.9MFY2025 · since FY2019: $39.0M → -$210.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$210.9M | -847.3% |
| FY2024 | -$22.3M | +44.2% |
| FY2023 | -$39.9M | +34.8% |
| FY2022 | -$61.2M | -17.2% |
| FY2021 | -$52.2M | -55.3% |
| FY2020 | -$33.6M | -186.3% |
| FY2019 | $39.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMRA financial trends
DMRA RevenueDMRA Net incomeDMRA Net marginDMRA Gross profitDMRA Gross marginDMRA Operating marginDMRA Operating cash flowDMRA Free cash flowDMRA Capital expendituresDMRA Return on equityDMRA Stock buybacksDMRA Dividends paidDMRA Total assetsDMRA Total liabilitiesDMRA Shareholders’ equityDMRA overview →